BCL2A1 |
NM_00409 |
112.53 |
BCL2-related protein A1 |
BIK |
NM_001197 |
17.31 |
BCL2-interacting killer |
CASP1 |
NM_033292 |
110.19 |
Caspase 1, apoptosis-related cysteine peptidase |
CASP10 |
NM_001230 |
14.56 |
Caspase 10, apoptosis-related cysteine peptidase |
CASP4 |
NM_001225 |
18.61 |
Caspase 4, apoptosis-related cysteine peptidase |
CD40 |
NM_001250 |
21.03 |
CD40 molecule, TNF receptor superfamily member 5 |
CD70 |
NM_001252 |
741.88 |
CD70 molecule |
FAS |
NM_000043 |
14.66 |
Fas (TNF receptor superfamily, member 6) |
GADD45A |
NM_001924 |
28.11 |
Growth arrest and DNA-damage-inducible, alpha |
HRK |
NM_003806 |
255.63 |
Harakiri, BCL2 interacting protein |
LTA |
NM_000595 |
44.36 |
Lymphotoxin alpha |
RIPK2 |
NM_003821 |
45.83 |
Receptor-interacting serine-threonine kinase 2 |
TNF |
NM_000594 |
776.28 |
Tumor necrosis factor |
TNFRSF10B |
NM_003842 |
18.78 |
Tumor necrosis factor receptor superfamily, member 10b |
TNFRSF9 |
NM_001561 |
887.03 |
Tumor necrosis factor ligand superfamily, member 9 |
TNFSF10 |
NM_003810 |
15.02 |
Tumor necrosis factor ligand superfamily, member 10 |